Anti-IL-6 antibody [EPR22565-204]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal IL-6 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 11 publications.
View Alternative Names
IFNB2, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, CTL differentiation factor, Hybridoma growth factor, Interferon beta-2, BSF-2, CDF, IFN-beta-2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-IL-6 antibody [EPR22565-204] (AB233551)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HUVEC (human umbilical vein endothelial cell) cells labeling IL-6 with ab233551 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining in HUVEC cells treated with lipopolysaccharide (0.5μg/ml) for 4 h, then together with Brefeldin A (300ng/ml) for another 20h. The nuclear counterstain is DAPI (blue). Counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at a 1/200 dilution (red). The negative control is the secondary antibody only.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-IL-6 antibody [EPR22565-204] (AB233551)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol permeabilized HUVEC (Human umbilical vein endothelial cell) treated with 0.5ug/ml LPS for 4h, then together with 300ng/ml BFA for another 20h (Red) / Untreated control (Green), labeling IL-6 with ab233551 at 1/400 (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-IL-6 antibody [EPR22565-204] (AB233551)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) (top) or PBMCs treated with LPS, 18 Hours, 1µg/mL (bottom), with ab233551 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left).
PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by incubation with the CD14 multistain. Cells were then fixed and permeabilised with BD Cytofix/Cytoperm™ for 20 min, and stained with the antibody ab233551 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.04 μg/ml (1/12)) for 30 min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.
- IP
Unknown
Immunoprecipitation - Anti-IL-6 antibody [EPR22565-204] (AB233551)
IL-6 was immunoprecipitated from 0.35 mg HUVEC (Human umbilical vein endothelial cell) treated with 0.5μg/ml LPS for 4h, then together with 300ng/ml BFA for another 20h whole cell lysate with ab233551 at 1/20 dilution. Western blot was performed from the immunoprecipitate using ab233551 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used at 1/5000 dilution.
Lane 1 : HUVEC treated as above whole cell lysate 10 μg (Input).
Lane 2 : ab233551 IP in HUVEC treated as above whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab233551 in HUVEC treated as above whole cell lysate.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 15 seconds.
All lanes:
Immunoprecipitation - Anti-IL-6 antibody [EPR22565-204] (ab233551)
Predicted band size: 23 kDa
Observed band size: 21 kDa,28 kDa
false
- WB
Lab
Western blot - Anti-IL-6 antibody [EPR22565-204] (AB233551)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000000 dilution.
In Western blot analysis, ab233706 exhibited lower sensitivity compared to ab233551, for which reason we recommend the latter one as superior alternative.
ab233706 does not work in THP-1 cell line due to sensitivity issue.
Lanes 1 - 2:
Western blot - Anti-IL-6 antibody [EPR21711] (<a href='/en-us/products/primary-antibodies/il-6-antibody-epr21711-ab233706'>ab233706</a>) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-IL-6 antibody [EPR22565-204] (ab233551) at 1/1000 dilution
Lanes 1 and 3:
Untreated HUVEC (human umbilical vein endothelial cell line) whole cell lysate at 20 µg
Lanes 2 and 4:
HUVEC treated with 0.5 ug/ml lipopolysaccharides (LPS) for 24 hours, added 300 ng/ml BFA last 20 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 23 kDa
false
Exposure time: 20s
- WB
Unknown
Western blot - Anti-IL-6 antibody [EPR22565-204] (AB233551)
The molecular weight observed is consistent with what has been described in the literature (PMID : 14970177).
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-IL-6 antibody [EPR22565-204] (ab233551) at 1/1000 dilution
Lane 1:
Untreated HUVEC (human umbilical vein endothelial cell) whole cell lysate at 20 µg
Lane 2:
HUVEC treated with 0.5 μg/ml LPS for 4 hours, then 300 ng/ml BFA (Brefeldin A) was added for the last 20 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 21 kDa,24 kDa
false
- WB
Lab
Western blot - Anti-IL-6 antibody [EPR22565-204] (AB233551)
False colour image of Western blot : Anti-IL-6 antibody [EPR22565-204] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab233551 was shown to bind specifically to IL-6. A band was observed at 25 kDa in wild-type A549 cell lysates with no signal observed at this size in IL6 knockout cell line ab273751 (knockout cell lysate ab275501). To generate this image, wild-type and IL6 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-IL-6 antibody [EPR22565-204] (ab233551) at 1/1000 dilution
Lane 1:
Wild-type A549 Vehicle Control IL-1b (0 ng/mL, 24 h), Brefeldin A (5 ug/mL, final 6 h) cell lysate at 30 µg
Lane 2:
Wild-type A549 Treated IL-1b (20 ng/mL, 24 h), Brefeldin A (5 ug/mL, final 6 h) cell lysate at 30 µg
Lane 3:
IL-6 knockout A549 Vehicle Control IL-1b (0 ng/mL, 24 h), Brefeldin A (5 ug/mL, final 6 h) cell lysate at 30 µg
Lane 4:
IL-6 knockout A549 Treated IL-1b (20 ng/mL, 24 h), Brefeldin A (5 ug/mL, final 6 h) cell lysate at 30 µg
Predicted band size: 23 kDa
Observed band size: 25 kDa
false
Related conjugates and formulations (3)
-
Anti-IL-6 antibody [EPR22565-204] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-IL-6 antibody [EPR22565-204]
-
578 PE
PE Anti-IL-6 antibody [EPR22565-204]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-6 influences immune regulation and acts as part of the acute phase response. It stimulates the production of acute-phase proteins and supports the differentiation of B cells into antibody-producing cells. IL-6 is not known to be part of a larger complex acting primarily as a single entity in signal transduction. Moreover IL-6 impacts the metabolism of iron and bone homeostasis showing its multifunctional nature.
Pathways
IL-6 forms an integral part of several signaling routes particularly the JAK-STAT pathway. In this context IL-6 interacts with signal transducer proteins like STAT3 to transmit signals from the cell surface to the nucleus affecting gene expression. Another important pathway is the MAPK pathway through which IL-6 influences cell proliferation and survival. These interactions reflect IL-6's diverse effects in cellular processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Molecular psychiatry : PubMed40993340
2025
Applications
Unspecified application
Species
Unspecified reactive species
Immunity, inflammation and disease 13:e70220 PubMed40642947
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of medical research 30:586 PubMed40624560
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:168 PubMed40186205
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of the rheumatic diseases 84:726-745 PubMed39237134
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 23:132 PubMed37407973
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:224 PubMed35222701
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 40:134 PubMed33858489
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neuroscience 487:120-130 PubMed33600884
2021
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental pharmacology & physiology 47:1850-1860 PubMed32603491
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com